87.38
Rhythm Pharmaceuticals Inc Azioni (RYTM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
11.61%
57.25
|
51.30 | 48.50 | 32.70 | 41.83 |
| Cost Of Revenue |
12.68%
4.802
|
5.499 | 5.543 | 3.648 | 3.787 |
| Gross Profit |
14.52%
52.45
|
45.80 | 42.96 | 29.06 | 38.04 |
|
|
1.08%
99.51
|
98.45 | 88.25 | 76.06 | 79.30 |
| Benefits Costs and Expenses |
0.67%
104.79
|
104.09 | 94.80 | 82.12 | 85.21 |
| Costs And Expenses |
0.35%
104.32
|
103.95 | 93.80 | 79.71 | 83.08 |
| Operating Income/Loss |
10.62%
-47.06
|
-52.65 | -45.30 | -47.00 | -41.26 |
| Nonoperating Income/Loss |
237.86%
-0.473
|
-0.14 | -0.999 | -2.414 | -2.127 |
| Income/Loss From Continuing Operations Before Tax |
9.96%
-47.54
|
-52.79 | -46.30 | -49.42 | -43.38 |
| Income Tax Expense/Benefit |
127.93%
-0.031
|
0.111 | 0.337 | 0.08 | -0.09 |
| Income/Loss From Continuing Operations After Tax |
10.21%
-47.51
|
-52.90 | -46.63 | -49.50 | -43.29 |
|
|
10.21%
-47.51
|
-52.90 | -46.63 | -49.50 | -43.29 |
| Preferred Stock Dividends And Other Adjustments |
3.13%
1.332
|
1.375 | - | - | 1.339 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.04%
0.6378
|
66.26 | 63.68 | 63.06 | 0.2019 |
| Diluted Average Shares |
99.04%
0.6378
|
66.26 | 63.68 | 63.06 | 0.2019 |
| Basic Earnings Per Share |
10.98%
-0.73
|
-0.82 | -0.75 | -0.81 | -0.72 |
| Diluted Earnings Per Share |
10.98%
-0.73
|
-0.82 | -0.75 | -0.81 | -0.72 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
3.13%
1.332
|
1.375 | - | - | 1.339 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):